 Connection
David Kroll to Phytotherapy
This is a "connection" page, showing publications David Kroll has written about Phytotherapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.683 |
|
|
|
-
Shaw HS, Kroll DJ. The convergence of herb pharmacodynamics and herb-drug interactions on hemostasis. Altern Ther Health Med. 2001 Nov-Dec; 7(6):46-7.
Score: 0.181
-
Winslow LC, Kroll DJ. Herbs as medicines. Arch Intern Med. 1998 Nov 09; 158(20):2192-9.
Score: 0.147
-
Ladas EJ, Kroll DJ, Oberlies NH, Cheng B, Ndao DH, Rheingold SR, Kelly KM. A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Cancer. 2010 Jan 15; 116(2):506-13.
Score: 0.080
-
Kroll DJ, Shaw HS, Oberlies NH. Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. Integr Cancer Ther. 2007 Jun; 6(2):110-9.
Score: 0.067
-
Basch E, Bent S, Foppa I, Haskmi S, Kroll D, Mele M, Szapary P, Ulbricht C, Vora M, Yong S. Marigold (Calendula officinalis L.): an evidence-based systematic review by the Natural Standard Research Collaboration. J Herb Pharmacother. 2006; 6(3-4):135-59.
Score: 0.060
-
Lee D, Li C, Graf TN, Vigo JS, Graham JG, Cabieses F, Farnsworth NR, Cordell GA, Kinghorn AD, Kroll DJ, Wani MC, Oberlies NH. Diterpene glycosides from Egletes viscosa. Planta Med. 2005 Aug; 71(8):792-4.
Score: 0.059
-
Kroll DJ, Shaw HS, Wall ME, Oberlies NH. Variability in St. John's wort formulations is an important consideration. Altern Ther Health Med. 2001 Nov-Dec; 7(6):21-2.
Score: 0.045
-
Peebles KA, Baker RK, Kurz EU, Schneider BJ, Kroll DJ. Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum). Biochem Pharmacol. 2001 Oct 15; 62(8):1059-70.
Score: 0.045
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|